One biotechnology and drugs player that insiders are buying a large amount of stock in is Aegerion Pharmaceuticals (AEGR). This company focused on the development and commercialization of therapeutics to treat lipid disorders. Insiders are buying this stock into strength, since shares are up over 40% in the last three months.
Aegerion Pharmaceuticals has a market cap of $29 million and an enterprise value of $450 million. Its estimated growth rate for this year is -20.6%, and for next year it's pegged 26.2%. This is a cash-rich company, since the total cash position on its balance sheet is $95.46 million and its total debt is $10.53 million.
A beneficial owner just bought 180,000 shares, or $3.86 million worth of stock, at $19.50 to $22.71 per share.From a technical perspective, AEGR is currently trending above both its 50-day and 200-day moving averages, which is bullish. This stock has been trending sideways for the last month and change, with shares moving between $18.33 on the downside and $23 on the upside. A high-volume move outside of that range soon will likely lead to the next major trend for shares of AEGR. If you're bullish on AEGR, then I would look for long-biased trades once this stock manages to break out above some near-term overhead resistance levels at $22.98 to $23 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 459,973 shares. If that breakout triggers soon, then AEGR will set up to re-test or possibly take out its next major overhead resistance level at $25.92 a share. Keep in mind that traders can also buy AEGR off weakness to anticipate that breakout as long as shares continue to trend above its 50-day at $19.04 a share. Juniper Networks Another name in the communications equipment complex that insiders are active in here is Juniper Networks (JNPR). This company designs, develops and sells innovative products and services that together provide its customers with high-performance network infrastructure built on simplicity, security, openness and scale. Insiders are buying this stock into some modest weakness, since shares are off by 11% so far in 2012.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV